2017 -- H 5738

========

LC001921

========

     STATE OF RHODE ISLAND

IN GENERAL ASSEMBLY

JANUARY SESSION, A.D. 2017

____________

A N   A C T

RELATING TO FOOD AND DRUGS -- UNIFORM CONTROLLED SUBSTANCES ACT

     

     Introduced By: Representatives Canario, Edwards, Bennett, Johnston, and O`Grady

     Date Introduced: March 01, 2017

     Referred To: House Judiciary

     (Attorney General)

It is enacted by the General Assembly as follows:

1

     SECTION 1. Section 21-28-2.08 of the General Laws in Chapter 21-28 entitled "Uniform

2

Controlled Substances Act" is hereby amended to read as follows:

3

     21-28-2.08. Contents of schedules.

4

     Schedule I

5

     (a) Schedule I shall consist of the drugs and other substances, by whatever official name,

6

common or usual name, chemical name, or brand name designated, listed in this section.

7

     (b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the

8

following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and

9

ethers whenever the existence of the isomers, esters, ethers, and salts is possible within the

10

specific chemical designation:

11

     (1) Acetylmethadol

12

     (2) Allylprodine

13

     (3) Alphacetylmethadol

14

     (4) Alphameprodine

15

     (5) Alphamethadol

16

     (6) Benzethidine

17

     (7) Betacetylmethadol

18

     (8) Betameprodine

19

     (9) Betamethadol

 

1

     (10) Betaprodine

2

     (11) Clonitazene

3

     (12) Dextromoramide

4

     (13) Difenoxin

5

     (14) Diampromide

6

     (15) Diethylthiambutene

7

     (16) Dimenoxadol

8

     (17) Dimepheptanol

9

     (18) Dimethylthiambutene

10

     (19) Dioxaphetyl butyrate

11

     (20) Dipipanone

12

     (21) Ethylmethylthiambutene

13

     (22) Etonitazene

14

     (23) Extoxerdine

15

     (24) Furethidine

16

     (25) Hydroxypethidine

17

     (26) Ketobemidone

18

     (27) Levomoramide

19

     (28) Levophenacylmorphan

20

     (29) Morpheridine

21

     (30) Noracymethadol

22

     (31) Norlevorphanol

23

     (32) Normethadone

24

     (33) Norpipanone

25

     (34) Phenadoxone

26

     (35) Phenampromide

27

     (36) Phenomorphan

28

     (37) Phenoperidine

29

     (38) Piritramide

30

     (39) Proheptazine

31

     (40) Properidine

32

     (41) Propiram

33

     (42) Racemoramide

34

     (43) Trimeperidone

 

LC001921 - Page 2 of 18

1

     (44) Tilidine

2

     (45) Alpha-methylfentanyl

3

     (46) Beta-hydroxy-3-methylfentanyl other names:

4

     N-[1-(2hydroxy-2-phenethyl)-3-methyl-4piperidingyl] Nphenylpropanamide

5

     (47) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-

6

phenylpropanamide)

7

     (48) N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide, its optical, positional, and

8

geometric isomers, salts and salts of isomers (Other names: acetyl fentanyl)

9

     (49) N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide

10

(Other names: beta-hydroxythiofentanyl)

11

     (50) N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide (Other names: Butyryl fentanyl)

12

     (51) N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide (Other names: Furanyl

13

fentanyl)

14

     (52) 3,4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl]benzamide (Other names:

15

AH-7921)

16

     (53) 3,4-Dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (Other names:

17

U-47700)

18

     (54) 3-Methylbutyrfentanyl (Other names: 3-MBF)

19

     (55) 4-Fluorobutyrfentanyl (Other names: 4-FBF, p-FBF)

20

     (56) 4-Phenylfentanyl

21

     (57) 4-Methoxybutyrfentanyl (Other names: 4-MeO-BF)

22

     (58) Acrylfentanyl (Other names: acryloyfentanyl)

23

     (59) Lofentanyl

24

     (60) N-Methylcarfentanyl

25

     (61) Ocfentanyl (INN, A-3217)

26

     (63) 4-methoxymethylfentanyl (Other names: R-30490)

27

     (64) 1-cyclohexyl-4-(1,2 diphenylethyl)piperazine) (Other names: MT-45, IC-6)

28

     (c) Opium Derivatives. Unless specifically excepted or unless listed in another schedule,

29

any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the

30

existence of the salts, isomers, and salts of isomers is possible within the specific chemical

31

designation:

32

     (1) Acetorphine

33

     (2) Acetyldihydrocodeine

34

     (3) Benzylmorphine

 

LC001921 - Page 3 of 18

1

     (4) Codeine methylbromide

2

     (5) Codeine-N-Oxide

3

     (6) Cyprenorphine

4

     (7) Desomorphine

5

     (8) Dihydromorphine

6

     (9) Etorphine (Except hydrochloride salt)

7

     (10) Heroin

8

     (11) Hydromorphinol

9

     (12) Methyldesorphine

10

     (13) Methylihydromorphine

11

     (14) Morphine methylbromide

12

     (15) Morphine methylsulfonate

13

     (16) Morphine-N-Oxide

14

     (17) Myrophine

15

     (18) Nococodeine

16

     (19) Nicomorphine

17

     (20) Normorphine

18

     (21) Pholcodine

19

     (22) Thebacon

20

     (23) Drotebanol

21

     (d) Hallucinogenic Substances. Unless specifically excepted or unless listed in another

22

schedule, any material, compound, mixture, or preparation that contains any quantity of the

23

following hallucinogenic substances, or that contains any of its salts, isomers, and salts of isomers

24

whenever the existence of the salts, isomers, and salts of isomers is possible within the specific

25

chemical designation (for purposes of this subsection only, the term "isomer" includes the optical,

26

position, and geometric isomers):

27

     (1) 3, 4-methylenedioxy amphetamine

28

     (2) 5-methoxy-3, 4-methylenedioxy amphetamine

29

     (3) 3, 4, 5-trimethoxy amphetamine

30

     (4) Bufotenine

31

     (5) Diethyltryptamine

32

     (6) Dimethyltryptamine

33

     (7) 4-methyl 2, 5-dimethoxyamphetamine

34

     (8) Ibogaine

 

LC001921 - Page 4 of 18

1

     (9) Lysergic acid diethylamide

2

     (10) Marihuana

3

     (11) Mescaline

4

     (12) Peyote. Meaning all parts of the plant presently classified botanically as Lophophora

5

Williamsii Lemair whether growing or not; the seeds of the plant; any extract from any part of the

6

plant; and any compound, manufacture, salt, derivative, mixture, or preparation of the plant, its

7

seeds or extracts.

8

     (13) N-ethyl-3-piperidyl benzilate

9

     (14) N-methyl-3-piperidyl benzilate

10

     (15) Psilocybin

11

     (16) Psilocyn

12

     (17) Tetrahydrocannabinols. Synthetic equivalents of the substances contained in the

13

plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives, and

14

their isomers with similar chemical structure and pharmacological activity such as the following:

15

delta 1 cis or trans tetrahydrocannabinol, and their optical isomers. Delta 6 cis or trans

16

tetrahydrocannabinol and their optical isomers. Delta 3, 4 cis or trans tetrahydrocannabinol and

17

their optical isomer. (Since nomenclature of these substances is not internationally standardized,

18

compounds of these structures, regardless of numerical designation of atomic positions covered).

19

     (18) Thiophene analog of phencyclidine. 1-(1-(2 thienyl) cyclo-hexyl) pipiridine: 2-

20

Thienyl analog of phencyclidine: TPCP

21

     (19) 2,5 dimethoxyamphetamine

22

     (20) 4-bromo-2,5-dimethoxyamphetamine, 4-bromo-2,5-dimethoxy-alpha-

23

methylphenethyamine: 4-bromo-2,5-DMA

24

     (21) 4-methoxyamphetamine-4-methoxy-alpha-methylphenethylaimine:

25

paramethoxyamphetamine: PMA

26

     (22) Ethylamine analog of phencyclidine. N-ethyl-1- phenylcyclohexylamine, (1-

27

phenylcyclohexyl) ethylamine, N-(1-phenylcyclophexyl) ethylamine, cyclohexamine, PCE

28

     (23) Pyrrolidine analog of phencyclidine. 1-(1-phencyclohexyl)- pyrrolidine PCPy, PHP

29

     (24) Parahexyl; some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-

30

trimethyl-6H-dibenz o (b,d) pyran: Synhexyl.

31

     (25) Salvia Divinorum (Salvinorin A or Divinorin A), meaning any extract from any part

32

of the plant, and any compound, salt derivative, or mixture of the plant or its extracts. This shall

33

not mean the unaltered plant.

34

     (26) Datura stamonium (jimsom weed or datura), meaning any extract from any part of

 

LC001921 - Page 5 of 18

1

the plant, and any compound, salt derivative, or mixture of the plant or its extracts. This shall not

2

mean the unaltered plant.

3

     (e) Depressants. Unless specifically excepted or unless listed in another schedule, any

4

material, compound, mixture, or preparation that contains any quantity of the following

5

substances having a depressant effect on the central nervous system, including its salts, isomers,

6

and salts of isomers whenever the existence of the salts, isomers, and salts of isomers is possible

7

within the specific chemical designation:

8

     (1) Mecloqualone.

9

     (2) Methaqualone.

10

     (3) 3-methyl fentanyl (n-(3methyl-1(2-phenylethyl)-4-piperidyl)-N-phenylpropanamide.

11

     (4) 3,4-methyl-enedioxymethamphetamine (MDMA), its optical, positional, and

12

geometric isomers, salts, and salts of isomers.

13

     (5) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP), its optical isomers, salts, and

14

salts of isomers.

15

     (6) 1-(2-phenylethyl)-4-phenyl-4-acetyloxypiperidine (PEPAP), its optical isomers, salts,

16

and salts of isomers.

17

     (7) N-(1-(1-methyl-2-phenyl)ethyl-4-piperidyl)-N-phenyl-acetamide (acetyl-alpha-

18

methylfentanyl), its optical isomers, salts, and salts of isomers.

19

     (8) N-(1-(1-methyl-2(2-thienyl)ethyl-4-piperidyl)-N-phenylpropanami de (alpha-

20

methylthiofentanyl), its optical isomers, salts, and salts of isomers.

21

     (9) N-(1-benzyl-piperidyl)-N-phenylpropanamide (benzyl-fentanyl), its optical isomers,

22

salts, and salts of isomers.

23

     (10) N-(1-(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenyl-propanamid e (beta-

24

hydroxyfentanyl), its optical isomers, salts, and salts of isomers.

25

     (11) N-(3-methyl-1(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenylpro panamide (beta-

26

hydroxy-3-methylfentanyl), its optical and geometric isomers, salts, and salts of isomers.

27

     (12) N-(3-methyl)-1-(2-(2-thienyl)ethyl-4-piperidyl)-N-phenylpro- panamide (3-

28

methylthiofentanyl), its optical and geometric isomers, salts, and salts of isomers.

29

     (13) N-(1-2-thienyl)methyl-4-piperidyl)-N-phenylpropanamide (thenylfentanyl), its

30

optical isomers, salts, and salts of isomers.

31

     (14) N-(1-(2(2-thienyl)ethyl-4-piperidyl-N-phenylpropanamide (thiofentanyl), its optical

32

isomers, salts, and salts of isomers.

33

     (15) N-[1-(2-phenylethyl)-4-piperidyl] N-(4-fluorophenyl)-propanamid e (para-

34

fluorofentanyl), its optical isomers, salts, and salts of isomers.

 

LC001921 - Page 6 of 18

1

     (16) Gamma hydroxybutyrate, HOOC-CH2-CH2-CH2OH, its optical, position, or

2

geometric isomers, salts, and salts of isomers.

3

     (f) Stimulants. Unless specifically excepted or unless listed in another schedule, any

4

material, compound, mixture, or preparation that contains any quantity of the following

5

substances having a stimulant effect on the central nervous system, including its salts, isomers,

6

and salts of isomers:

7

     (1) Fenethylline

8

     (2) N-ethylamphetamine

9

     (3) 4-methyl-N-methylcathinone (Other name: mephedrone)

10

     (4) 3,4-methylenedioxy-N-methlycathinone (Other name: methylone)

11

     (5) 3,4-methylenedioxypyrovalerone (Other name: MDPV)

12

     (g) Any material, compound, mixture, or preparation that contains any quantity of the

13

following substances:

14

     (1) 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl] phenol (CP-47,497)

15

     (2) 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl] phenol

16

(cannabicyclohexanol and CP-47,497 c8 homologue)

17

     (3) 1-Butyl-3-(1 naphthoyl)indole, (JWH-073)

18

     (4) 1-[2-(4-Morpholinyl)ethyl] 3-(1-naphthoyl)indole (JWH-200)

19

     (5) 1-Pentyl-3-(1-napthoyl)indole, (JWH-018 and AM678)

20

     (h) Synthetic cannabinoids or piperazines. Unless specifically excepted, any chemical

21

compound which is not approved by the United States Food and Drug Administration or, if

22

approved, which is not dispensed or possessed in accordance with state and federal law, that

23

contains Benzylpiperazine (BZP); Trifluoromethylphenylpiperazine (TFMPP); 1,1-

24

Dimethylheptyl-11-hydroxytetrahydrocannabinol (HU-210); 1-Butyl-3-(1-naphthoyl) indole; 1-

25

Pentyl-3-(1-naphthoyl) indole; dexanabinol (HU-211); or any compound in the following

26

structural classes:

27

     (1) Naphthoylindoles: Any compound containing a 3-(1-naphthoyl)indole structure with

28

substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl,

29

cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl

30

group, whether or not further substituted in the indole ring to any extent and whether or not

31

substituted in the naphthyl ring to any extent. Examples of this structural class include, but are not

32

limited, to JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, and AM-

33

2201;

34

     (2) Phenylacetylindoles: Any compound containing a 3-phenylacetylindole structure with

 

LC001921 - Page 7 of 18

1

substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl,

2

cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl

3

group whether or not further substituted in the indole ring to any extent and whether or not

4

substituted in the phenyl ring to any extent. Examples of this structural class include, but are not

5

limited to, JWH-167, JWH-250, JWH-251, and RCS-8;

6

     (3) Benzoylindoles: Any compound containing a 3-(benzoyl) indole structure with

7

substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl,

8

cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl

9

group whether or not further substituted in the indole ring to any extent and whether or not

10

substituted in the phenyl ring to any extent. Examples of this structural class include, but are not

11

limited, to AM-630, AM-2233, AM-694, Pravadoline (WIN 48,098), and RCS-4;

12

     (4) Cyclohexylphenols: Any compound containing a 2-(3-hydroxycyclohexyl)phenol

13

structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl,

14

cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl

15

group whether or not substituted in the cyclohexyl ring to any extent. Examples of this structural

16

class include, but are not limited to, CP 47,497 and its C8 homologue (cannabicyclohexanol);

17

     (5) Naphthylmethylindoles: Any compound containing a 1H-indol-3-yl-(1-naphthyl)

18

methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl,

19

alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-

20

morpholinyl)ethyl group whether or not further substituted in the indole ring to any extent and

21

whether or not substituted in the naphthyl ring to any extent. Examples of this structural class

22

include, but are not limited to, JWH-175, JWH-184, and JWH-185;

23

     (6) Naphthoylpyrroles: Any compound containing a 3-(1-naphthoyl)pyrrole structure

24

with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl,

25

cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl

26

group whether or not further substituted in the pyrrole ring to any extent and whether or not

27

substituted in the naphthyl ring to any extent. Examples of this structural class include, but are not

28

limited, to JWH-030, JWH-145, JWH-146, JWH-307, and JWH-368;

29

     (7) Naphthylmethylindenes: Any compound containing a 1-(1-naphthylmethyl)indene

30

structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl,

31

cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl

32

group whether or not further substituted in the indene ring to any extent and whether or not

33

substituted in the naphthyl ring to any extent. Examples of this structural class include, but are not

34

limited to, JWH-176; or

 

LC001921 - Page 8 of 18

1

     (8) Any other synthetic cannabinoid or piperazine which is not approved by the United

2

States Food and Drug Administration or, if approved, which is not dispensed or possessed in

3

accordance with state and federal law;

4

     (i) Synthetic cathinones. Unless specifically excepted, any chemical compound which is

5

not approved by the United States Food and Drug Administration or, if approved, which is not

6

dispensed or possessed in accordance with state and federal law, not including bupropion,

7

structurally derived from 2-aminopropan-1-one by substitution at the 1-position with either

8

phenyl, naphthyl, or thiophene ring systems, whether or not the compound is further modified in

9

one or more of the following ways:

10

     (1) By substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy,

11

haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system

12

by one or more other univalent substituents. Examples of this class include, but are not limited to,

13

3,4-Methylenedioxycathinone (bk-MDA);

14

     (2) By substitution at the 3-position with an acyclic alkyl substituent. Examples of this

15

class include, but are not limited to, 2-methylamino-1-phenylbutan-1-one (buphedrone);

16

     (3) By substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or

17

methoxybenzyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure.

18

Examples of this class include, but are not limited to, Dimethylcathinone, Ethcathinone, and a-

19

Pyrrolidinopropiophenone (a-PPP); or

20

     (4) Any other synthetic cathinone which is not approved by the United States Food and

21

Drug Administration or, if approved, is not dispensed or possessed in accordance with state or

22

federal law;

23

     Schedule II

24

     (a) Schedule II shall consist of the drugs and other substances, by whatever official name,

25

common or usual name, chemical name, or brand name designated, listed in this section.

26

     (b) Substances, vegetable origin, or chemical synthesis. Unless specifically excepted or

27

unless listed in another schedule, any of the following substances whether produced directly or

28

indirectly by extraction from substances of vegetable origin, or independently by means of

29

chemical synthesis, or by a combination of extraction and chemical synthesis:

30

     (1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or

31

opiate excluding naloxone and its salts, and excluding naltrexone and its salts, but including the

32

following:

33

     (i) Raw opium

34

     (ii) Opium extracts

 

LC001921 - Page 9 of 18

1

     (iii) Opium fluid extracts

2

     (iv) Powdered opium

3

     (v) Granulated opium

4

     (vi) Tincture of opium

5

     (vii) Etorphine hydrochloride

6

     (viii) Codeine

7

     (ix) Ethylmorphine

8

     (x) Hydrocodone

9

     (xi) Hydromorphone

10

     (xii) Metopon

11

     (xiii) Morphine

12

     (xiv) Oxycodone

13

     (xv) Oxymorphone

14

     (xvi) Thebaine

15

     (2) Any salt, compound, derivative, or preparation that is chemically equivalent or

16

identical with any of the substances referred to in subdivision (1) of this subsection, except that

17

these substances shall not include the isoquinoline alkaloids of opium.

18

     (3) Opium poppy and poppy straw.

19

     (4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and

20

any salt, compound, derivative, or preparation that is chemically equivalent or identical with any

21

of these substances, except that the substances shall not include decocainized coca leaves or

22

extraction of coca leaves, which extractions do not contain cocaine or ecgonine.

23

     (5) Concentrate of poppy straw (the crude extract of poppy straw in liquid, solid, or

24

powder form that contains the phenanthrine alkaloids of the opium poppy).

25

     (c) Opiates. Unless specifically excepted or unless listed in another schedule, any of the

26

following opiates, including its isomers, esters, ethers, salts; and salts of isomers, esters, and

27

ethers whenever the existence of the isomers, esters, ethers, and salts is possible within the

28

specific chemical designation:

29

     (1) Alphaprodine

30

     (2) Anileridine

31

     (3) Bezitramide

32

     (4) Dihydrocodeine

33

     (5) Diphenoxylate

34

     (6) Fentanyl

 

LC001921 - Page 10 of 18

1

     (7) Isomethadone

2

     (8) Levomethorphan

3

     (9) Levorphanol

4

     (10) Metazocine

5

     (11) Methadone

6

     (12) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane

7

     (13) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic

8

acid

9

     (14) Pethidine

10

     (15) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine

11

     (16) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate

12

     (17) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid

13

     (18) Phenaxocine

14

     (19) Piminodine

15

     (20) Racemethorphan

16

     (21) Racemorphan

17

     (22) Bulk Dextropropoxyphene (non-dosage forms)

18

     (23) Suffentanil

19

     (24) Alfentanil

20

     (25) Levoalphacetylmethadol

21

     (26) Carfentanil

22

     (27) Remifentanil

23

     (d) Stimulants. Unless specifically excepted or unless listed in another schedule, any

24

material, compound, mixture, or preparation that contains any quantity of the following

25

substances having a stimulant effect on the central nervous system:

26

     (1) Amphetamine, its salts, optical isomers, and salts of its optical isomers.

27

     (2) Methamphetamine, its salts, and salts of its isomers.

28

     (3) Phenmetrazine and its salts.

29

     (4) Methylphenidate.

30

     (e) Depressants. Unless specifically excepted or unless listed in another schedule, any

31

material, compound, mixture, or preparation that contains any quantity of the following

32

substances having a depressant effect on the central nervous system, including its salts, isomers,

33

and salts of isomers whenever the existence of the salts, isomers, and salts of isomers is possible

34

within the specific chemical designation:

 

LC001921 - Page 11 of 18

1

     (1) Amobarbital

2

     (2) Glutethimide

3

     (3) Methyprylon

4

     (4) Pentobarbital

5

     (5) Phencyclidine

6

     (6) Secobarbital

7

     (7) Phencyclidine immediate precursors:

8

     (i) 1-phencyclohexylamine

9

     (ii) 1-piperidinocyclohexane-carbonitrile (PCC)

10

     (8) Immediate precursor to amphetamine and methamphetamine: Phenylacetone. Some

11

other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzone ketone.

12

     Schedule III

13

     (a) Unless specifically excepted or unless listed in another schedule, any material,

14

compound, mixture, or preparation that contains any quantity of the following substances having

15

a depressant effect on the central nervous system:

16

     (1) Any substance that contains any quantity of a derivative of barbituric acid or any salt

17

of a derivative of barbituric acid.

18

     (2) Chlorhexadol

19

     (3) Lysergic acid

20

     (4) Lysergic acid amide

21

     (5) Sulfondiethylmethane

22

     (6) Sulfonethylmethane

23

     (7) Sylfonmethane

24

     (8) Any compound, mixture, or preparation containing amobarbital, secobarbital,

25

pentobarbital, or any salt of them and one or more other active medicinal ingredients that are not

26

listed in any schedule.

27

     (9) Any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or

28

any salt of any of these drugs and approved by the Food and Drug Administration for marketing

29

only as a suppository.

30

     (10) Ketamine, its salts, isomers, and salts of isomers. (Some other names for ketamine:

31

(+)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone).

32

     (b) Unless specifically excepted or unless listed in another schedule, any material,

33

compound, mixture, or preparation containing limited quantities of any of the following narcotic

34

drugs, or any salts of them:

 

LC001921 - Page 12 of 18

1

     (1) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred

2

milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with an equal

3

or greater quantity of an isoquinoline alkaloid of opium.

4

     (2) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred

5

milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with one or

6

more active, nonnarcotic ingredients in recognized therapeutic amounts.

7

     (3) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one

8

hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with

9

a fourfold or greater quantity of an isoquinoline alkaloid of opium.

10

     (4) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one

11

hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with

12

one or more active nonnarcotic ingredients in recognized therapeutic amounts.

13

     (5) Not more than one and eight tenths grams (1.8 gms.) of dihydrocodeine per one

14

hundred milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with

15

one or more active nonnarcotic ingredients in recognized therapeutic amounts.

16

     (6) Not more than three hundred milligrams (300 mgs.) of ethylmorphine per one

17

hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with

18

one or more active nonnarcotic ingredients in recognized therapeutic amounts.

19

     (7) Not more than five hundred milligrams (500 mgs.) of opium per one hundred

20

milliliters (100 mls.) or per one hundred grams (100 gms.) or not more than twenty-five

21

milligrams (25 mgs.) per dosage unit, with one or more active nonnarcotic ingredients in

22

recognized therapeutic amounts.

23

     (8) Not more than fifty milligrams (50 mgs.) of morphine per one hundred milliliters (100

24

mls.) per one hundred grams (100 gms.) with one or more active, nonnarcotic ingredients in

25

recognized therapeutic amounts.

26

     (c) Stimulants. Unless specifically excepted or listed in another schedule, any material,

27

compound, mixture, or preparation that contains any quantity of the following substances having

28

a stimulant effect on the central nervous system, including its salts, isomers, and salts of the

29

isomers whenever the existence of the salts of isomers is possible within the specific chemical

30

designation:

31

     (1) Benzphetamine

32

     (2) Chlorphentermine

33

     (3) Clortermine

34

     (4) Mazindol

 

LC001921 - Page 13 of 18

1

     (5) Phendimetrazine

2

     (d) Steroids and hormones. Anabolic steroids (AS) or human growth hormone (HGH),

3

excluding those compounds, mixtures, or preparations containing an anabolic steroid that because

4

of its concentration, preparation, mixture, or delivery system, has no significant potential for

5

abuse, as published in 21 CFR 1308.34, including, but not limited to, the following:

6

     (1) Chlorionic gonadotropin

7

     (2) Clostebol

8

     (3) Dehydrochlormethyltestosterone

9

     (4) Ethylestrenol

10

     (5) Fluoxymesterone

11

     (6) Mesterolone

12

     (7) Metenolone

13

     (8) Methandienone

14

     (9) Methandrostenolone

15

     (10) Methyltestosterone

16

     (11) Nandrolone decanoate

17

     (12) Nandrolone phenpropionate

18

     (13) Norethandrolone

19

     (14) Oxandrolone

20

     (15) Oxymesterone

21

     (16) Oxymetholone

22

     (17) Stanozolol

23

     (18) Testosterone propionate

24

     (19) Testosterone-like related compounds

25

     (20) Human Growth Hormone (HGH)

26

     (e) Hallucinogenic substances.

27

     (1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in U.S.

28

Food and Drug Administration-approved drug product. (Some other names for dronabinol: (6aR-

29

trans)-6a, 7, 8, 10a- tetrahydro-6, 6, 9- trimethyl-3-pentyl-6H- dibenzo[b,d] yra n-1-ol,or(-)-delta-

30

9(trans)-tetrahydrocannabinol.)

31

     Schedule IV

32

     (1) Barbital.

33

     (2) Chloral betaine

34

     (3) Chloral hydrate

 

LC001921 - Page 14 of 18

1

     (4) Ethchrovynol

2

     (5) Ethinamate

3

     (6) Methohexital

4

     (7) Meprobamate

5

     (8) Methylphenobarbital

6

     (9) Paraldehyde

7

     (10) Petrichloral

8

     (11) Phenobarbital

9

     (12) Fenfluramine

10

     (13) Diethylpropion

11

     (14) Phentermine

12

     (15) Pemoline (including organometallic complexes and chelates thereof).

13

     (16) Chlordiazepoxide

14

     (17) Clonazepam

15

     (18) Clorazepate

16

     (19) Diazepam

17

     (20) Flurazepam

18

     (21) Mebutamate

19

     (22) Oxazepam

20

     (23) Unless specifically excepted or unless listed in another schedule, any material,

21

compound, mixture, or preparation that contains any quantity of the following substances,

22

including its salts:

23

     Dextropropoxyphene(alpha-(+)-4-dimethylamino-1,2-diphenyl-3- methyl-2-

24

propronoxybutane).

25

     (24) Prazepam

26

     (25) Lorazepam

27

     (26) Not more than one milligram (1 mg.) of difenoxin and not less than twenty-five (25)

28

micrograms of atropine sulfate per dosage unit.

29

     (27) Pentazocine

30

     (28) Pipradrol

31

     (29) SPA (-)-1-dimethylamino-1, 2-diphenylethane

32

     (30) Temazepam

33

     (31) Halazepam

34

     (32) Alprazolam

 

LC001921 - Page 15 of 18

1

     (33) Bromazepam

2

     (34) Camazepam

3

     (35) Clobazam

4

     (36) Clotiazepam

5

     (37) Cloxazolam

6

     (38) Delorazepam

7

     (39) Estazolam

8

     (40) Ethyl Ioflazepate

9

     (41) Fludizaepam

10

     (42) Flunitrazepam

11

     (43) Haloxazolam

12

     (44) Ketazolam

13

     (45) Loprazolam

14

     (46) Lormetazepam

15

     (47) Medazepam

16

     (48) Nimetazepam

17

     (49) Nitrazepam

18

     (50) Nordiazepam

19

     (51) Oxazolam

20

     (52) Pinazepam

21

     (53) Tetrazepam

22

     (54) Mazindol

23

     (55) Triazolam

24

     (56) Midazolam

25

     (57) Quazepam

26

     (58) Butorphanol

27

     (59) Sibutramine

28

     Schedule V

29

     (a) Any compound, mixture, or preparation containing any of the following limited

30

quantities of narcotic drugs, which shall include one or more non-narcotic active medicinal

31

ingredients in sufficient proportion to confer upon the compound, mixture, or preparation

32

valuable medicinal qualities other than those possessed by the narcotic drug alone:

33

     (1) Not more than two hundred milligrams (200 mgs.) of codeine per 100 milliliters (100

34

mls.) or per one hundred grams (100 gms.).

 

LC001921 - Page 16 of 18

1

     (2) Not more than one hundred milligrams (100 mgs.) of dihydrocodeine per 100

2

milliliters (100 mls.) or per one hundred grams (100 gms.).

3

     (3) Not more than one hundred milligrams (100 mgs.) of ethylmorphine per 100

4

milliliters (100 mls.) or per one hundred grams (100 gms.).

5

     (4) Not more than two and five tenths milligrams (2.5 mgs.) of diphenixylate and not less

6

than twenty-five (25) micrograms of atropine sulfate per dosage unit.

7

     (5) Not more than one hundred milligrams (100 mgs.) of opium per one hundred

8

milliliters (100 mls.) or per one hundred grams (100 gms.).

9

     (b) Not more than five tenths milligrams (0.5 mgs.) of difenoxin and not less than twenty-

10

five (25) micrograms of atropine sulfate per dosage unit.

11

     (c) Buprenorphine

12

     (d) Unless specifically exempted or excluded or unless listed in another schedule, any

13

material, compound, mixture, or preparation that contains any quantity of the following

14

substances having a stimulant effect on the central nervous system, including its salts, isomers,

15

and salts of isomers:

16

     (1) Propylhexedrine (except as benzedrex inhaler)

17

     (2) Pyrovalerone.

18

     SECTION 2. This act shall take effect upon passage.

========

LC001921

========

 

LC001921 - Page 17 of 18

EXPLANATION

BY THE LEGISLATIVE COUNCIL

OF

A N   A C T

RELATING TO FOOD AND DRUGS -- UNIFORM CONTROLLED SUBSTANCES ACT

***

1

     This act would include fentanyl analogs and synthetic opioids into Schedule I and

2

Schedule II of the list of uniform controlled substances.

3

     This act would take effect upon passage.

========

LC001921

========

 

LC001921 - Page 18 of 18